↓ Skip to main content

Receptor for Advanced Glycation End Products Acts as a Fuel to Colorectal Cancer Development

Overview of attention for article published in Frontiers in oncology, September 2020
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
44 Dimensions

Readers on

mendeley
70 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Receptor for Advanced Glycation End Products Acts as a Fuel to Colorectal Cancer Development
Published in
Frontiers in oncology, September 2020
DOI 10.3389/fonc.2020.552283
Pubmed ID
Authors

Fatemeh Azizian-Farsani, Navid Abedpoor, Mohammad Hasan Sheikhha, Ali Osmay Gure, Mohammad Hossein Nasr-Esfahani, Kamran Ghaedi

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 70 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 70 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 10 14%
Student > Bachelor 7 10%
Student > Doctoral Student 6 9%
Student > Master 4 6%
Researcher 3 4%
Other 11 16%
Unknown 29 41%
Readers by discipline Count As %
Medicine and Dentistry 16 23%
Biochemistry, Genetics and Molecular Biology 14 20%
Pharmacology, Toxicology and Pharmaceutical Science 4 6%
Immunology and Microbiology 3 4%
Agricultural and Biological Sciences 2 3%
Other 6 9%
Unknown 25 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 September 2023.
All research outputs
#20,320,284
of 25,838,141 outputs
Outputs from Frontiers in oncology
#9,506
of 22,812 outputs
Outputs of similar age
#316,897
of 435,093 outputs
Outputs of similar age from Frontiers in oncology
#282
of 672 outputs
Altmetric has tracked 25,838,141 research outputs across all sources so far. This one is in the 18th percentile – i.e., 18% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,812 research outputs from this source. They receive a mean Attention Score of 3.1. This one is in the 49th percentile – i.e., 49% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 435,093 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 23rd percentile – i.e., 23% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 672 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.